Clinical Trial Update: Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating multiple doses and regimens of cabozantinib in grade IV astrocytic tumors at first or second relapse was terminated, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytic Tumors

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: Exelixis | Conditions: Astrocytic Tumors | Phase 2 | Status: TERMINATED | Results posted: 2026-02-25